Skip to content
Rameda Pharma
Rameda Pharma
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact
Corporate Website
  • ع
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact

Yearly Archives: 2021

You are here:
  1. Home
  2. 2021

Disclosure to EGX on EGM minutes

Regulatory DisclosuresBy adminNovember 25, 2021

Disclosure to EGX on AGM minutes

Regulatory DisclosuresBy adminNovember 25, 2021

Rameda Reports its 3Q21 Results

Corporate NewsBy adminNovember 15, 2021

EGX disclosure regarding the upcoming OGM 25 November 2021

Regulatory DisclosuresBy adminNovember 1, 2021

EGX Disclosure on BOD and shareholding structure

Regulatory DisclosuresBy adminOctober 12, 2021

Disclosure to EGX on BOD minutes

Regulatory DisclosuresBy adminOctober 6, 2021

Disclosure to EGX on EGM minutes

Regulatory DisclosuresBy adminAugust 24, 2021

Rameda Reports its 2Q21 Results

Corporate NewsBy adminAugust 9, 2021

Equinox Pharma Holding Limited (Equinox) increases its stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.

Corporate NewsBy adminJuly 28, 2021

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. acquires a sizeable molecule in a fast-growing therapeutic area

Corporate NewsBy adminJuly 15, 2021
→123→

All Rights Reserved © 2024

Go to Top